Role of hypercapnia on the lung airways
Role of hypercapnia on the lung airways
批准号:
9903435
负责人:
Jacob I Sznajder
金额:
$46.72万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2023-02-28
关键词:
AcidosisActinsAcuteAffectApplications GrantsBacterial InfectionsBloodBronchopulmonary DysplasiaCASP7 geneCSPG4 geneCalcineurinCalpainCarbon DioxideCarotid BodyCell physiologyCellsChronicChronic Obstructive Airway DiseaseChronic lung diseaseClinicalCytoskeletonDataDepositionDiseaseDown-RegulationDsRedExposure toExtracellular MatrixG ActinGasesGlomus CellGuidelinesHealthHumanHypercapniaHypoxiaImmune responseImpairmentIn VitroIndividualIntensive Care UnitsKnockout MiceLeadLungLung diseasesMorbidity - disease rateMusMuscleMuscle ContractionMuscle functionNitric OxideOutcomeOxygenPPP3CA genePartial PressurePathway interactionsPatientsPreparationReportingResearchResearch PersonnelRoleSerumSignal PathwaySliceSmooth Muscle MyocytesTestingTissuesTransgenic OrganismsUnited StatesValidationVirus Diseasesadverse outcomeairway hyperresponsivenessairway remodelingalveolar epitheliumbody sensecofilinconnective tissue growth factordesignexperimental studyin vivoinsightknock-downmortalitynovelnovel therapeuticspaxillinpolymerizationpreventrespiratory smooth muscletranscriptome
中文摘要
项目摘要
氧气和一氧化氮激活细胞信号通路,这对肺部健康很重要
和疾病。然而,对肺细胞(其他细胞)
比颈动脉体)感知并响应二氧化碳(CO2)浓度的变化。一个
CO2(高碳酸血症)水平的增加通常是由于
肺部疾病,如慢性阻塞性肺病(COPD)等。
美国约有1700万人患有COPD,目前是第三大慢性阻塞性肺病。
是全球死亡率的主要原因。一些研究报告称,
COPD和高碳酸血症的预后更差。然而,肺结核患者的高碳酸血症
疾病在很大程度上是可以耐受的,因为仍然存在高碳酸血症的影响不是
对肺部有害。最近的研究,包括我们自己的研究,已经表明,
CO2激活特定的细胞内信号通路,对肺和
有机体功能我们已经进行了实验,使用无偏见的,假设生成,
以及假设驱动的方法,这些方法已经产生了关于影响的初步数据,
高碳酸血症的症状我们在准备这笔赠款的初步结果
应用表明,高CO2水平激活特定的信号通路,导致变化
呼吸道收缩性。因此,我们建议阐明信号通路,
高碳酸血症增加气道收缩性和平滑肌细胞的机制
通过三个相互关联的具体目标发挥作用。在关于具体目标1的实验中,我们将
确定高碳酸血症是否通过
caspase-7的激活和miR-133 a-MEF 2D的下调。在研究中,
具体目标2,我们将确定是否高碳酸血症增加肌动蛋白聚合
从而通过RhoA和钙调神经磷酸酶调节气道平滑肌收缩,
关于具体目标3,我们将确定高碳酸血症通过以下方式促进气道重塑:
通过RhoA-SRF和/或Wnt-CTGF途径增加αSMA和细胞外基质。
这些实验的完成将为信号通路提供新的信息
以及高CO2水平导致肺气道高反应性的机制,
这对慢性肺病患者如COPD和高碳酸血症的重要性。
英文摘要
Project Summary
Oxygen and nitric oxide activate cellular signaling pathways, which are important in lung health
and diseases. However, much less is known about the mechanisms by which lung cells (other
than carotid bodies) sense and respond to changes in carbon dioxide (CO2) concentrations. An
increase in the levels of CO2 (hypercapnia) is often a consequence of impaired gas exchange in
lung diseases such as chronic obstructive pulmonary disease (COPD) and others.
Approximately 17 million individuals in the US are afflicted by COPD, which now is the 3rd
leading cause of overall mortality worldwide. Several studies have reported that patients with
COPD and hypercapnia have worse outcomes. However, hypercapnia in patients with lung
diseases is largely tolerated as there is still the notion that the effects of hypercapnia are not
harmful to the lungs. Recent studies, including our own, have demonstrated that elevations in
CO2 activate specific intracellular signaling pathways with adverse consequences for lung and
organismal functions. We have conducted experiment using unbiased, hypotheses-generating,
as well as hypotheses-driven approaches, which have generated preliminary data on the effects
of hypercapnia on the lungs airways. Our preliminary results in preparation for this grant
application suggest that high CO2 levels activate specific signaling pathways leading to changes
in airway contractility. As such, we propose to elucidate the signaling pathways and
mechanisms by which hypercapnia increases airway contractility and smooth muscle cell
function via three interrelated specific aims. In experiments pertaining specific aim 1, we will
determine whether hypercapnia increases airway smooth muscle contraction via
activation of caspase-7 and downregulation of miR-133a-MEF2D. In studies pertaining
specific aim 2, we will determine whether hypercapnia increases actin polymerization
and thus airway smooth muscle contractility via RhoA and calcineurin and in studies
pertaining specific aim 3, we will determine hypercapnia promotes airway remodeling by
increasing αSMA and extracellular matrix via RhoA-SRF and/or Wnt-CTGF pathway.
Completion of the proposed experiments will provide novel information on signaling pathways
and mechanisms by which high CO2 levels lead to lung airways hyperreactivity, which is of
importance for patients with chronic lung diseases such as COPD and hypercapnia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of hypercapnia on the lung airways
-
批准号:10115793
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2019
-
负责人:Jacob I Sznajder
-
依托单位:
Role of hypercapnia on the lung airways
-
批准号:10369052
-
项目类别:
-
资助金额:$45.29万
-
财政年份:2019
-
负责人:Jacob I Sznajder
-
依托单位:
Pathophysiology of Alveolar Epithelial Lung Injury
-
批准号:7824799
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2009
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:7824414
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2009
-
负责人:Jacob I Sznajder
-
依托单位:
Recruitment of New Faculty to Enhance Research in Lung Biology
-
批准号:7936173
-
项目类别:
-
资助金额:$44.62万
-
财政年份:2009
-
负责人:Jacob I Sznajder
-
依托单位:
Recruitment of New Faculty to Enhance Research in Lung Biology
-
批准号:7858936
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2009
-
负责人:Jacob I Sznajder
-
依托单位:
Effects of hypoxia on the alveolar epthelium
-
批准号:7435394
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2007
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:7256236
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:8384840
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:8584306
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:7651282
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:7433225
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:8212333
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The deleterious effects of hypercapnia on the lungs
-
批准号:8817060
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:8041372
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The injurious effects of hypercapnia on the alveolar epithelium
-
批准号:7137490
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
The deleterious effects of hypercapnia on the lungs
-
批准号:9173059
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2006
-
负责人:Jacob I Sznajder
-
依托单位:
Training Program in Lung Biology
-
批准号:6876577
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2004
-
负责人:Jacob I Sznajder
-
依托单位:
Training Program In Lung Sciences
-
批准号:9386040
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2004
-
负责人:Jacob I Sznajder
-
依托单位:
Training Program in Lung Science
-
批准号:7776836
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2004
-
负责人:Jacob I Sznajder
-
依托单位:
海外基金